The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
Open accessAbstract
The term ‘sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first‐ and advanced‐line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204424 · Cited by 2,886
Self-citationPolymyositis and Dermatomyositis: (Second of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920807 · Cited by 2,447
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Cyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Self-citationSystemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Mayes, M. D., Lacey, J. V., Beebe‐Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., & Schottenfeld, D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11073 · Cited by 935
Walker, U. A., Tyndall, A., Czirják, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., Müller-Ladner, U., Bocelli-Tyndall, C., & Matucci-Cerinic, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062901 · Cited by 929
Self-citationvan Laar, J. M., Farge, D., Sont, J. K., Naraghi, K., Marjanovic, Z., Larghero, J., Schuerwegh, A. J., Marijt, E. W. A., Vonk, M. C., Schattenberg, A. V., et al. (2014) · JAMA · doi:10.1001/jama.2014.6368 · Cited by 766
Self-citationKorn, J. H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J. R., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20676 · Cited by 728
Self-citationKowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 619
Self-citationKoenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, É., Grodzicky, T., Raymond, Y., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24038 · Cited by 615
Burt, R. K., Shah, S. J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60982-3 · Cited by 578
Stein, B., Rahmsdorf, H. J., Steffen, A., Litfin, M., & Herrlich, P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.5169 · Cited by 524
Matucci-Cerinic, M., Denton, C. P., Furst, D. E., Mayes, M. D., Hsu, V. M., Carpentier, P., Wigley, F. M., Black, C. M., Fessler, B. J., Merkel, P. A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130658 · Cited by 498
Self-citationRituximab in the treatment of dermatomyositis: An open‐label pilot study
Levine, T. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20849 · Cited by 440
Wigley, F. M., Wise, R. A., Seibold, J. R., McCloskey, D. A., Kujala, G., Medsger, T. A., Steen, V. D., Varga, J., Jimenez, S., Mayes, M., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00004 · Cited by 421
Lee, J. S., Collard, H. R., Anstrom, K. J., Martinez, F. J., Noth, I., Roberts, R. S., Yow, E., & Raghu, G. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70105-x · Cited by 413
Fett, N., & Werth, V. P. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.05.045 · Cited by 394
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo
Scharffetter, K., Wlaschek, M., Hogg, A., Bolsen, K., Schothorst, A., Goerz, G., Krieg, T., & Plewig, G. (1991) · Archives of Dermatological Research · doi:10.1007/bf00371923 · Cited by 394
Self-citationLaxer, R. M., & Zulian, F. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000245727.40630.c3 · Cited by 373
The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
Peterson, L. S., Nelson, A. M., Su, W. P. D., et al. (1997) · PubMed · Cited by 366
Localized scleroderma in childhood is not just a skin disease
Zulian, F., Vallongo, C., Woo, P., Russo, R., Ruperto, N., Harper, J., Espada, G., Corona, F., Mukamel, M., Vesely, R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21264 · Cited by 364
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Noordegraaf, A. V., Beghetti, M., et al. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.01.002 · Cited by 357
VAN DEN HOOGEN, F. H. J., BOERBOOMS, A. M. T., SWAAK, A. J. G., RASKER, J. J., VAN LIER, H. J. J., & VAN DE PUTTE, L. B. A. (1996) · Rheumatology · doi:10.1093/rheumatology/35.4.364 · Cited by 355
Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy
Fries, R., Shariat, K., von Wilmowsky, H., & Böhm, M. (2005) · Circulation · doi:10.1161/circulationaha.104.523324 · Cited by 337
Clements, P. J., Furst, D. E., Wong, W.-K., Mayes, M., White, B., Wigley, F., Weisman, M. H., Barr, W., Moreland, L. W., Medsger Jr., T. A., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1194::aid-anr16>3.0.co;2-7 · Cited by 330
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
Herrick, A. L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.96 · Cited by 302
Solomon, J. J., Olson, A. L., Fischer, A., Bull, T., Brown, K. K., & Raghu, G. (2013) · European Respiratory Review · doi:10.1183/09059180.00005512 · Cited by 294
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
Thompson, A. E., Shea, B., Welch, V., Fenlon, D., & Pope, J. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1841::aid-art322>3.0.co;2-8 · Cited by 290
Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Moinzadeh, P., Muller-Ladner, U., Pfeiffer, C., Riemekasten, G., et al. (2008) · Rheumatology · doi:10.1093/rheumatology/ken179 · Cited by 287
Self-citationTreatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine
Coleiro, B., Marshall, S. E., Denton, C. P., Howell, K., Blann, A., Welsh, K. I., & Black, C. M. (2001) · Rheumatology · doi:10.1093/rheumatology/40.9.1038 · Cited by 261
Self-citationDistinct Autoimmune Syndromes in Morphea: A Review of 245 Adult and Pediatric Cases
Leitenberger, J. J., Cayce, R. L., Haley, R. W., Adams-Huet, B., Bergstresser, P. R., & Jacobe, H. T. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.79 · Cited by 259
Kreuter, A., Hyun, J., Stücker, M., Sommer, A., Altmeyer, P., & Gambichler, T. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.11.1063 · Cited by 249
Self-citationGuía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Noordegraaf, A. V., Beghetti, M., et al. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.01.002 · Cited by 240
High-dose UVA1 radiation therapy for localized scleroderma
Stege, H., Berneburg, M., Humke, S., Klammer, M., Grewe, M., Grether‐Beck, S., Boedeker, R., Diepgen, T. L., Diercks, K., Goerz, G., et al. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80277-0 · Cited by 235
Guidelines on the use of extracorporeal photopheresis
Knobler, R., Berlin, G., Calzavara‐Pinton, P., Greinix, H., Jaksch, P., Laroche, L., Ludvigsson, J., Quaglino, P., Reinisch, W., Scarisbrick, J., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12311 · Cited by 221
Self-citationZulian, F., Martini, G., Vallongo, C., Vittadello, F., Falcini, F., Patrizi, A., Alessio, M., Torre, F. L., Podda, R. A., Gerloni, V., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30264 · Cited by 216
Weibel, L., Sampaio, M. C., Visentin, M. T., Howell, K. J., Woo, P., & Harper, J. I. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07497.x · Cited by 216
Arkachaisri, T., Vilaiyuk, S., Torok, K. S., & Medsger, T. A. (2010) · Rheumatology · doi:10.1093/rheumatology/kep361 · Cited by 215
Overlap connective tissue disease syndromes
Iaccarino, L., Gatto, M., Bettio, S., Caso, F., Rampudda, M., Zen, M., Ghirardello, A., Punzi, L., & Doria, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.06.004 · Cited by 197
Low-dose UVA1 phototherapy for treatment of localized scleroderma
Kerscher, M., Volkenandt, M., Gruss, C. J., Reuther, T., von Kobyletzki, G., Freitag, M., Dirschka, T., & Altmeyer, P. J. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70533-x · Cited by 197
Topical calcipotriene for morphea/linear scleroderma
Cunningham, B. B., Landells, I. D. R., Langman, C., Sailer, D. E., & Paller, A. S. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70077-5 · Cited by 193
Roustit, M., Blaise, S., Allanore, Y., Carpentier, P. H., Caglayan, E., & Cracowski, J.-L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202836 · Cited by 185
ARKACHAISRI, T., VILAIYUK, S., LI, S., O’NEIL, K. M., POPE, E., HIGGINS, G. C., PUNARO, M., RABINOVICH, E. C., ROSENKRANZ, M., KIETZ, D. A., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081284 · Cited by 183
Carubbi, F., Cipriani, P., Marrelli, A., Benedetto, P. D., Ruscitti, P., Berardicurti, O., Pantano, I., Liakouli, V., Alvaro, S., Alunno, A., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4359 · Cited by 182
Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
Pope, J., Fenlon, D., Thompson, A., Shea, B., Furst, D., Wells, G. A., & Silman, A. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000953 · Cited by 180
Association of Autoimmune Diseases with Lichen Sclerosus in 532 Male and Female Patients
Kreuter, A., Kryvosheyeva, Y., Terras, S., Moritz, R., Möllenhoff, K., Altmeyer, P., Scola, N., & Gambichler, T. (2013) · Acta Dermato Venereologica · doi:10.2340/00015555-1512 · Cited by 179
Self-citationAN EPIDEMIOLOGICAL STUDY OF SCLERODERMA IN THE WEST MIDLANDS
SILMAN, A., JANNINI, S., SYMMONS, D., & BACON, P. (1988) · Rheumatology · doi:10.1093/rheumatology/27.4.286 · Cited by 174
Mierau, R., Moinzadeh, P., Riemekasten, G., Melchers, I., Meurer, M., Reichenberger, F., Buslau, M., Worm, M., Blank, N., Hein, R., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3495 · Cited by 171
Self-citationLocalized scleroderma is an autoimmune disorder
Takehara, K. (2005) · Rheumatology · doi:10.1093/rheumatology/keh487 · Cited by 164
Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1
Higley, H., Persichitte, K., Chu, S., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370218 · Cited by 157
Systemic and localized scleroderma
Chung, L. S., Lin, J., Furst, D. E., & Fiorentino, D. F. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.07.004 · Cited by 144
Clinical and Serological Hallmarks of Systemic Sclerosis Overlap Syndromes
Pákozdi, A., Nihtyanova, S. I., Moinzadeh, P., Ong, V. H., Black, C. M., & Denton, C. P. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.101248 · Cited by 142
Self-citationMeta‐Analysis of Healing and Prevention of Digital Ulcers in Systemic Sclerosis
Tingey, T. M., Shu, J., Smuczek, J., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.22018 · Cited by 136
Skin disease: a cardinal feature of systemic sclerosis
Krieg, T., & Takehara, K. (2006) · Rheumatology · doi:10.1093/rheumatology/kep108 · Cited by 135
Self-citationHulshof, M. M., Bavinck, J. N. B., Bergman, W. A., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.108369 · Cited by 130
In Vitro Evidence for a Direct Antifibrotic Role of the Immunosuppressive Drug Mycophenolate Mofetil
Roos, N., Poulalhon, N., Farge, D., Madelaine, I., Mauviel, A., & Verrecchia, F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117051 · Cited by 120
Habets, W. J., Rooij, D. J. D., Salden, M., et al. (1983) · PubMed · Cited by 117
Ihn, H., Sato, S., Fujimoto, M., Kikuchi, K., & Takehara, K. (1995) · Archives of Dermatological Research · doi:10.1007/bf01262331 · Cited by 116
Esophageal Involvement in Scleroderma: Gastroesophageal Reflux, the Common Problem
Ntoumazios, S. K., Voulgari, P. V., Potsis, K., Koutis, E., Tsifetaki, N., & Assimakopoulos, D. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.08.002 · Cited by 114
Vitali, C., Bootsma, H., Bowman, S., Dörner, T., Gottenberg, J., Mariette, X., Ramos‐Casals, M., Ravaud, P., Séror, R., Theander, E., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202565 · Cited by 98
Breuckmann, F., Gambichler, T., Altmeyer, P. J., & Kreuter, A. (2004) · BMC Dermatology · doi:10.1186/1471-5945-4-11 · Cited by 97
Self-citationLocalized scleroderma in childhood: A report of 30 cases
Uziel, Y., Krafchik, B. R., Silverman, E. D., Thorner, P. S., & Laxer, R. M. (1994) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(94)90028-0 · Cited by 95
Hunzelmann, N., Anders, S., Fierlbeck, G., Hein, R., Herrmalm, K., Albrecht, M., Bell, S., Muche, R., Wehner‐Caroli, J., Gaus, W., et al. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80221-6 · Cited by 92
Self-citationProbiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention.
Frech, T., Khanna, D., Maranian, P., Frech, E. J., Sawitzke, A. D., & Murtaugh, M. A. (2011) · PubMed · Cited by 90
Phosphodiesterase Type 5 Inhibition Is a Novel Therapeutic Option in Raynaud Disease
Caglayan, E., Huntgeburth, M., Karasch, T., Weihrauch, J., Hunzelmann, N., Krieg, T., Erdmann, E., & Rosenkranz, S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.231 · Cited by 87
Self-citationGambichler, T., Terras, S., & Kreuter, A. (2013) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2013.01.011 · Cited by 82
Self-citationTreatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)
Enomoto, D. N. H., Mekkes, J. R., Bossuyt, P. M., Yongd, S.-L., Outd, T. A., Hoekzema, R., de Rie, M. A., Schellekens, P. T. A., ten Berge, I. J. M., de Borgieb, C. A. J. M., et al. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70246-x · Cited by 81
Systemic sclerosis at the crossroad of polyautoimmunity
Elhaï, M., Avouac, J., Kahan, A., & Allanore, Y. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.002 · Cited by 80
Andres, C., Kollmar, A., Mempel, M., Hein, R., Ring, J., & Eberlein, B. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09438.x · Cited by 79
Assessment of skin, joint, tendon and muscle involvement.
Åkesson, A., FIORI, G., Krieg, T. M., van den Hoogen, F. H. J., & Seibold, J. R. (2003) · PubMed · Cited by 77
Self-citationAutoantibodies and overlap syndromes in autoimmune rheumatic disease
Jury, E. C., D’Cruz, D. P., & Morrow, W. J. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.5.340 · Cited by 74
Kreuter, A., Hyun, J., Skrygan, M., Sommer, A., Bastian, A., Altmeyer, P. J., & Gambichler, T. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07391.x · Cited by 72
Self-citationPapa, N. D., Onida, F., Zaccara, E., Saporiti, G., Maglione, W., Tagliaferri, E., Andracco, R., Vincenti, D., Montemurro, T., Mircoli, L., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.211 · Cited by 72
Camacho, N. D. R., Sánchez, J. E., Martín, R., González, J. R. E., & Sánchez, J. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117735 · Cited by 71
Bongi, S. M., Rosso, A. D., Passalacqua, M., Miccio, S., & Matucci‐Cerinic, M. (2011) · Arthritis Care & Research · doi:10.1002/acr.20487 · Cited by 65
Foocharoen, C., Tyndall, A., HACHULLA, E., Rosato, E., Allanore, Y., Farge, D., Caramaschi, P., Airó, P., Nikolaevna, S. M., da Silva, J. A. P., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3748 · Cited by 65
Self-citationTreatment of Small Intestinal Disease in Systemic Sclerosis With Octreotide
Nikou, G. C., Toumpanakis, C., Katsiari, C. G., et al. (2007) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e3180645d2a · Cited by 64
Jacobe, H. T., Cayce, R. L., & Nguyen, J. K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08672.x · Cited by 60
Effect of Increased Pigmentation on the Antifibrotic Response of Human Skin to UV-A1 Phototherapy
Wang, F., Garza, L. A., Cho, S., Kafi, R., Hammerberg, C., Quan, T., Hamilton, T. A., Mayes, M. D., Ratanatharathorn, V., Voorhees, J. J., et al. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.7.851 · Cited by 59
Diagnosis and Therapy of Localized Scleroderma
Kreuter, A., Krieg, T. M., Worm, M., Wenzel, J., Gambichler, T., Kuhn, A., Aberer, E., Scharffetter‐Kochanek, K., & Hunzelmann, N. (2009) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2009.07178.x · Cited by 57
Self-citationExpert Agreement on EULAR/EUSTAR Recommendations for the Management of Systemic Sclerosis: Table 1.
Walker, K. M., & Pope, J. E. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.101262 · Cited by 56
Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma
Tomimura, S., Ogawa, F., Iwata, Y., Komura, K., Hara, T., Muroi, E., Takenaka, M., Shimizu, K., Hasegawa, M., Fujimoto, M., et al. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.04.013 · Cited by 54
Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis
Papp, G., Horváth, I. F., Baráth, S., Gyimesi, E., Végh, J., Szodoray, P., & Zeher, M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.09.014 · Cited by 54
Chemokines and Chemokine Receptors in Scleroderma
Yamamoto, T. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000094242 · Cited by 48
Stausbøl‐Grøn, B., Olesen, A. B., Deleuran, B. W., & Deleuran, M. S. (2011) · Acta Dermato Venereologica · doi:10.2340/00015555-1136 · Cited by 45
Valentini, G. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.11.002 · Cited by 37
Imatinib treatment of generalized localized scleroderma (morphea)
Moinzadeh, P., Krieg, T. M., & Hunzelmann, N. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.030 · Cited by 37
Self-citationDinsdale, G., Murray, A. K., MOORE, T. L., Ferguson, J., Wilkinson, J., Richards, H. L., Griffiths, C. E. M., & Herrick, A. L. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu006 · Cited by 36
Familial Autoimmunity in Systemic Sclerosis — Results of a French-based Case-Control Family Study
Koumakis, E., Dieudé, P., Avouac, J., Kahan, A., & Allanore, Y. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111104 · Cited by 33
Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases
Murray, A. K., MOORE, T. L., Richards, H. L., Ennis, H., Griffiths, C. E. M., & Herrick, A. L. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11019.x · Cited by 26
Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma
Gambichler, T., Skrygan, M., Labanski, A. A., et al. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.05.003 · Cited by 26
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Pope (2001) · doi:10.1002/1529-0131(200106)44:6<1351::aid-art227>3.0.co;2-i
Cited by
Choi, S., Kim, J., Lee, J. H., Lee, Y. N., & Lee, J. H. (2023) · Acta Dermato-Venereologica · doi:10.2340/actadv.v103.11953 · Cited by 5
Metadata
- Authors
- Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Braae Olesen, A., Foeldvari, I., Frances, C., Jalili, A., Just, U., Kähäri, V., Kárpáti, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkötter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., & Krieg, T.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2017-08-09
- Volume
- 31
- Issue
- 9
- Pages
- 1401-1424
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2742848686
- Cited by
- 261
- References
- 98
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.